目的 探討前列倍喜膠囊聯(lián)合普適泰片治療前列腺增生的臨床效果。方法 選取2015年2月-2017年2月靖邊縣人民醫(yī)院泌尿外科收治的300例前列腺增生患者為研究對(duì)象，隨機(jī)分為對(duì)照組和治療組，每組各150例。對(duì)照組患者口服普適泰片，1片/次，2次/d。治療組患者在對(duì)照組治療基礎(chǔ)上口服前列倍喜膠囊，6粒/次，3次/d。所有患者均連續(xù)治療3個(gè)月。觀察兩組的臨床療效，比較兩組治療前后國(guó)際前列腺癥狀（IPSS）評(píng)分、生活質(zhì)量（QOL）評(píng)分、殘余尿量、前列腺體積和最大尿流率的變化情況。結(jié)果 治療后，對(duì)照組和治療組的總有效率分別為84.0%、95.3%，兩組總有效率比較差異有統(tǒng)計(jì)學(xué)意義（P<0.05）。治療后兩組患者IPSS評(píng)分、QOL評(píng)分、殘余尿量、前列腺體積均顯著降低，最大尿流率顯著升高，同組治療前后差異有統(tǒng)計(jì)學(xué)意義（P<0.05）；治療后治療組IPSS評(píng)分、QOL評(píng)分、殘余尿量、前列腺體積均顯著低于對(duì)照組，最大尿流率高于對(duì)照組，兩組比較差異有統(tǒng)計(jì)學(xué)意義（P<0.05）。結(jié)論 前列倍喜膠囊聯(lián)合普適泰片治療前列腺增生具有較好的臨床療效，可顯著改善患者的臨床癥狀，提高患者生活質(zhì)量，具有一定的臨床推廣應(yīng)用價(jià)值。

Objective To explore the clinical effect of Qianlie Beixi Capsules combined with Prostat Tablets in treatment of prostatic hyperplasia. Methods Patients (300 cases) with prostatic hyperplasia in Department of Urinary Surgery of Jingbian County People's Hospital from February 2015 to February 2017 were randomly divided into control (150 cases) and treatment (150 cases) groups. Patients in the control group were po administered with Prostat Tablets, 1 tablet/time, twice daily. Patients in the treatment group were po administered with Qianlie Beixi Capsules on the basis of the control group, 6 grains/time, three times daily. All patients were continuously treated for 3 months. After treatment, the clinical efficacy was evaluated, and the IPSS scores, QOL scores, residual urine volume, prostate volume and maximum urinary flow rate in two groups before and after treatment were compared. Results After treatment, the clinical efficacy in the control and treatment groups were 84.0% and 95.3%, respectively, and there was difference between two groups (P<0.05). After treatment, IPSS scores, QOL scores, residual urine volume, and prostate volume in two groups were significantly decreased, but maximum urinary flow rate significantly increased, and the difference was statistically significant in the same group (P<0.05). After treatment, IPSS scores, QOL scores, residual urine volume, and prostate volume in the treatment group were lower than those in the control group, maximum urinary flow rate was higher than that in the control group, and there was difference between two groups (P<0.05). Conclusion Qianlie Beixi Capsules combined with Prostat Tablets has a significant effect in treatment of prostatic hyperplasia, and can significantly improve the clinical symptoms, and improve the life quality, which has a certain clinical application value.